Rapid weight loss, especially when using GLP-1 medications, can sometimes lead to hair loss (alopecia)
Existing treatments Are current medications (e.g., GLP-1 agonists, SGLT-2 inhibitors) already addressing metabolic risk factors, and how effective have they been
Its important to note that GLP-1 is prescribed as part of a comprehensive weight management program, which includes dietary changes and increased physical activity
These include the short-acting agents exenatide twice daily (BID) (13), intermediate-acting liraglutide (administered once daily) (14), and the long-acting agents administered once weekly (QW), including exenatide QW (15), albiglutide (16), and dulaglutide (17)
"The market demand is currently for weekly agents with a higher level of efficacy," she said
Each year, more than 1,000 people are diagnosed with C3G in the United States alone